The document reviews key advancements in digital health, focusing on remote monitoring, telemedicine, and digital intervention efficacy. It summarizes research findings from various studies, including those on diabetes management and wearable devices, while highlighting the ongoing need for more evidence in specific areas such as virtual reality and blockchain technology. Additionally, it discusses the FDA’s role in approving new technologies that could enhance adherence and monitoring in chronic care settings.